Click for best price
Orphan Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 143200 million
|
Forecast Market size by 2029 |
US$ 269190 million
|
| Growth Rate |
CAGR of 9.4% |
Number of Pages |
62 Pages |
An orphan drug is a pharmaceutical agent developed to treat medical conditions which, because they are so rare, would not be profitable to produce without government assistance. The conditions are referred to as orphan diseases.
This report aims to provide a comprehensive presentation of the global market for Orphan Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orphan Drugs. This report contains market size and forecasts of Orphan Drugs in global, including the following market information:
Global Orphan Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Orphan Drugs market was valued at US$ 143200 million in 2022 and is projected to reach US$ 269190 million by 2029, at a CAGR of 9.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Bristol-Myers Squibb is one of the most important global key players of orphan drugs, holds a share of about 10%, other key players include Roche and Novartis, etc. North America is the largest market, occupied for about 40 percent, followed by Asia-Pacific. In terms of type, oncology is the largest segment, with a share of over 60%, and in terms of application, the adult segment holds a share of about 40 percent.
We surveyed the Orphan Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orphan Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Orphan Drugs Market Segment Percentages, by Type, 2022 (%)
Oncology
Pulmonary
Neurology
Hematology
Endocrinology
Cardio-vascular
Metabolic Disorders
Others
Global Orphan Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Orphan Drugs Market Segment Percentages, by Application, 2022 (%)
Baby and Child
Teenager
Adult
Other
Global Orphan Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Orphan Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orphan Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Orphan Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Roche
Novartis
Johnson & Johnson
Pfizer
Amgen
Sanofi
AstraZeneca
Takeda
Vertex Pharmaceuticals
AbbVie
Biogen
Eli Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orphan Drugs, market overview.
Chapter 2: Global Orphan Drugs market size in revenue.
Chapter 3: Detailed analysis of Orphan Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orphan Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Orphan Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 143200 million
|
| Forecast Market size by 2029 |
US$ 269190 million
|
| Growth Rate |
CAGR of 9.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Orphan Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orphan Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orphan Drugs Overall Market Size
2.1 Global Orphan Drugs Market Size: 2022 VS 2029
2.2 Global Orphan Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Orphan Drugs Players in Global Market
3.2 Top Global Orphan Drugs Companies Ranked by Revenue
3.3 Global Orphan Drugs Revenue by Companies
3.4 Top 3 and Top 5 Orphan Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Orphan Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orphan Drugs Players in Global Market
3.6.1 List of Global Tier 1 Orphan Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Orphan Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Orphan Drugs Market Size Markets, 2022 & 2029
4.1.2 Oncology
4.1.3 Pulmonary
4.1.4 Neurology
4.1.5 Hematology
4.1.6 Endocrinology
4.1.7 Cardio-vascular
4.1.8 Metabolic Disorders
4.1.9 Others
4.2 By Type - Global Orphan Drugs Revenue & Forecasts
4.2.1 By Type - Global Orphan Drugs Revenue, 2018-2023
4.2.2 By Type - Global Orphan Drugs Revenue, 2024-2029
4.2.3 By Type - Global Orphan Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Orphan Drugs Market Size, 2022 & 2029
5.1.2 Baby and Child
5.1.3 Teenager
5.1.4 Adult
5.1.5 Other
5.2 By Application - Global Orphan Drugs Revenue & Forecasts
5.2.1 By Application - Global Orphan Drugs Revenue, 2018-2023
5.2.2 By Application - Global Orphan Drugs Revenue, 2024-2029
5.2.3 By Application - Global Orphan Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Orphan Drugs Market Size, 2022 & 2029
6.2 By Region - Global Orphan Drugs Revenue & Forecasts
6.2.1 By Region - Global Orphan Drugs Revenue, 2018-2023
6.2.2 By Region - Global Orphan Drugs Revenue, 2024-2029
6.2.3 By Region - Global Orphan Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Orphan Drugs Revenue, 2018-2029
6.3.2 US Orphan Drugs Market Size, 2018-2029
6.3.3 Canada Orphan Drugs Market Size, 2018-2029
6.3.4 Mexico Orphan Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Orphan Drugs Revenue, 2018-2029
6.4.2 Germany Orphan Drugs Market Size, 2018-2029
6.4.3 France Orphan Drugs Market Size, 2018-2029
6.4.4 U.K. Orphan Drugs Market Size, 2018-2029
6.4.5 Italy Orphan Drugs Market Size, 2018-2029
6.4.6 Russia Orphan Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Orphan Drugs Market Size, 2018-2029
6.4.8 Benelux Orphan Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Orphan Drugs Revenue, 2018-2029
6.5.2 China Orphan Drugs Market Size, 2018-2029
6.5.3 Japan Orphan Drugs Market Size, 2018-2029
6.5.4 South Korea Orphan Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Orphan Drugs Market Size, 2018-2029
6.5.6 India Orphan Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Orphan Drugs Revenue, 2018-2029
6.6.2 Brazil Orphan Drugs Market Size, 2018-2029
6.6.3 Argentina Orphan Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Orphan Drugs Revenue, 2018-2029
6.7.2 Turkey Orphan Drugs Market Size, 2018-2029
6.7.3 Israel Orphan Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Orphan Drugs Market Size, 2018-2029
6.7.5 UAE Orphan Drugs Market Size, 2018-2029
7 Orphan Drugs Companies Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Orphan Drugs Major Product Offerings
7.1.4 Bristol-Myers Squibb Orphan Drugs Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Orphan Drugs Major Product Offerings
7.2.4 Roche Orphan Drugs Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Orphan Drugs Major Product Offerings
7.3.4 Novartis Orphan Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Orphan Drugs Major Product Offerings
7.4.4 Johnson & Johnson Orphan Drugs Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Orphan Drugs Major Product Offerings
7.5.4 Pfizer Orphan Drugs Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Orphan Drugs Major Product Offerings
7.6.4 Amgen Orphan Drugs Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Orphan Drugs Major Product Offerings
7.7.4 Sanofi Orphan Drugs Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Orphan Drugs Major Product Offerings
7.8.4 AstraZeneca Orphan Drugs Revenue in Global Market (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Takeda
7.9.1 Takeda Company Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Orphan Drugs Major Product Offerings
7.9.4 Takeda Orphan Drugs Revenue in Global Market (2018-2023)
7.9.5 Takeda Key News & Latest Developments
7.10 Vertex Pharmaceuticals
7.10.1 Vertex Pharmaceuticals Company Summary
7.10.2 Vertex Pharmaceuticals Business Overview
7.10.3 Vertex Pharmaceuticals Orphan Drugs Major Product Offerings
7.10.4 Vertex Pharmaceuticals Orphan Drugs Revenue in Global Market (2018-2023)
7.10.5 Vertex Pharmaceuticals Key News & Latest Developments
7.11 AbbVie
7.11.1 AbbVie Company Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Orphan Drugs Major Product Offerings
7.11.4 AbbVie Orphan Drugs Revenue in Global Market (2018-2023)
7.11.5 AbbVie Key News & Latest Developments
7.12 Biogen
7.12.1 Biogen Company Summary
7.12.2 Biogen Business Overview
7.12.3 Biogen Orphan Drugs Major Product Offerings
7.12.4 Biogen Orphan Drugs Revenue in Global Market (2018-2023)
7.12.5 Biogen Key News & Latest Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Company Summary
7.13.2 Eli Lilly Business Overview
7.13.3 Eli Lilly Orphan Drugs Major Product Offerings
7.13.4 Eli Lilly Orphan Drugs Revenue in Global Market (2018-2023)
7.13.5 Eli Lilly Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Orphan Drugs Market Opportunities & Trends in Global Market
Table 2. Orphan Drugs Market Drivers in Global Market
Table 3. Orphan Drugs Market Restraints in Global Market
Table 4. Key Players of Orphan Drugs in Global Market
Table 5. Top Orphan Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Orphan Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Orphan Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Orphan Drugs Product Type
Table 9. List of Global Tier 1 Orphan Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orphan Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Orphan Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Orphan Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Orphan Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Orphan Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Orphan Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Orphan Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Orphan Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Orphan Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Orphan Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Orphan Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Orphan Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Orphan Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Orphan Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Orphan Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Orphan Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Orphan Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Orphan Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Orphan Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Orphan Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Bristol-Myers Squibb Company Summary
Table 31. Bristol-Myers Squibb Orphan Drugs Product Offerings
Table 32. Bristol-Myers Squibb Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Bristol-Myers Squibb Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Orphan Drugs Product Offerings
Table 36. Roche Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Orphan Drugs Product Offerings
Table 40. Novartis Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Orphan Drugs Product Offerings
Table 44. Johnson & Johnson Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Orphan Drugs Product Offerings
Table 48. Pfizer Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Orphan Drugs Product Offerings
Table 52. Amgen Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Orphan Drugs Product Offerings
Table 56. Sanofi Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Orphan Drugs Product Offerings
Table 60. AstraZeneca Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Takeda Company Summary
Table 63. Takeda Orphan Drugs Product Offerings
Table 64. Takeda Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Takeda Key News & Latest Developments
Table 66. Vertex Pharmaceuticals Company Summary
Table 67. Vertex Pharmaceuticals Orphan Drugs Product Offerings
Table 68. Vertex Pharmaceuticals Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Vertex Pharmaceuticals Key News & Latest Developments
Table 70. AbbVie Company Summary
Table 71. AbbVie Orphan Drugs Product Offerings
Table 72. AbbVie Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. AbbVie Key News & Latest Developments
Table 74. Biogen Company Summary
Table 75. Biogen Orphan Drugs Product Offerings
Table 76. Biogen Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Biogen Key News & Latest Developments
Table 78. Eli Lilly Company Summary
Table 79. Eli Lilly Orphan Drugs Product Offerings
Table 80. Eli Lilly Orphan Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Eli Lilly Key News & Latest Developments
List of Figures
Figure 1. Orphan Drugs Segment by Type in 2022
Figure 2. Orphan Drugs Segment by Application in 2022
Figure 3. Global Orphan Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Orphan Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Orphan Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Orphan Drugs Revenue in 2022
Figure 8. By Type - Global Orphan Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Orphan Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Orphan Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Orphan Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Orphan Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Orphan Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Orphan Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Orphan Drugs Revenue Market Share, 2018-2029
Figure 16. US Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Orphan Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Orphan Drugs Revenue Market Share, 2018-2029
Figure 28. China Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Orphan Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Orphan Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Orphan Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Bristol-Myers Squibb Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AstraZeneca Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Takeda Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Vertex Pharmaceuticals Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. AbbVie Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Biogen Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Eli Lilly Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
